{"id":1272,"date":"2022-10-13T13:10:06","date_gmt":"2022-10-13T17:10:06","guid":{"rendered":"https:\/\/www.calian.com\/resources\/blogs\/calian-cares-syantra-and-calian-collaborate-to-provide-access-to-innovative-breast-cancer-screening-blood-test\/"},"modified":"2025-01-27T14:00:47","modified_gmt":"2025-01-27T19:00:47","slug":"calian-cares-syantra-and-calian-collaborate-to-provide-access-to-innovative-breast-cancer-screening-blood-test","status":"publish","type":"blog","link":"https:\/\/www.calian.com\/resources\/fr\/blogues\/calian-cares-syantra-and-calian-collaborate-to-provide-access-to-innovative-breast-cancer-screening-blood-test\/","title":{"rendered":"Calian CARES : Syantra et Calian collaborent pour permettre l’acc\u00e8s \u00e0 un test sanguin innovant de d\u00e9pistage du cancer du sein"},"content":{"rendered":"
<\/div>\n
\nSelon la Soci\u00e9t\u00e9 canadienne du cancer<\/a>, une Canadienne sur huit d\u00e9veloppera un cancer du sein au cours de sa vie et une sur trente-quatre en mourra. Comme pour tout cancer, la d\u00e9tection pr\u00e9coce est essentielle pour obtenir de meilleurs r\u00e9sultats.<\/p>\n

La mammographie est l’outil de d\u00e9pistage du cancer du sein le plus r\u00e9pandu depuis les ann\u00e9es 1960. Cependant, 45 % des femmes ont un tissu mammaire dense, ce qui rend plus difficile l’\u00e9valuation des r\u00e9sultats de la mammographie. Le tissu mammaire dense est \u00e9galement li\u00e9 \u00e0 un risque plus \u00e9lev\u00e9 de cancer du sein. En outre, de nombreuses femmes ne commencent pas \u00e0 se faire d\u00e9pister r\u00e9guli\u00e8rement avant d’avoir atteint l’\u00e2ge de 50 ans, ce qui donne aux tumeurs plus de temps pour se d\u00e9velopper avant d’\u00eatre d\u00e9tect\u00e9es.<\/p>\n

Conscient de ces limites, un groupe de chercheurs de l’Universit\u00e9 de Calgary, dirig\u00e9 par Bob Shepherd, cofondateur et pr\u00e9sident de Syantra, et le Dr Tina Rinker, cofondatrice et responsable scientifique de Syantra, a commenc\u00e9 \u00e0 d\u00e9velopper un nouvel outil de d\u00e9pistage du cancer du sein. L’\u00e9quipe a mis au point le test Syantra DX | Breast Cancer, un test sanguin qui mesure un panel de biomarqueurs d’expression g\u00e9n\u00e9tique et utilise ensuite un logiciel d’apprentissage automatique pour interpr\u00e9ter les donn\u00e9es. En 2021, Syantra Inc. a re\u00e7u l’accr\u00e9ditation du College of Physicians and Surgeons of Alberta (CPSA) pour le test sanguin de d\u00e9pistage du cancer du sein Syantra DX, le mettant ainsi \u00e0 la disposition du public.<\/p>\n

Calian s’est associ\u00e9 \u00e0 Syantra<\/a>pour mettre ce nouvel outil de d\u00e9pistage \u00e0 la disposition des femmes dans plus de 100 villes au Canada. “Gr\u00e2ce \u00e0 notre r\u00e9seau d’infirmi\u00e8res mobiles et \u00e0 la plateforme num\u00e9rique Calian\u00ae Nexi\u2122, nous \u00e9liminons les obstacles \u00e0 l’acc\u00e8s des femmes \u00e0 ce moyen de d\u00e9pistage r\u00e9volutionnaire”, d\u00e9clare Kaytlin Sadler, vice-pr\u00e9sidente des solutions pour les patients chez Calian.”Conscient que le prix de vente au d\u00e9tail du test, qui s’\u00e9l\u00e8ve \u00e0 499 dollars, peut constituer un obstacle \u00e0 l’acc\u00e8s, Calian met \u00e9galement les patientes en relation avec les options de financement disponibles dans le cadre du programme de soutien aux patientes de Syantra.<\/p>\n

Les \u00e9tudes cliniques ont d\u00e9montr\u00e9 un taux de pr\u00e9cision de 92,2 % pour les femmes \u00e2g\u00e9es de 25 \u00e0 80 ans et de 98,5 % pour les femmes de moins de 50 ans. Ce chiffre est comparable aux taux de pr\u00e9cision des mammographies, qui identifient correctement environ 87 % des cancers du sein dans l’ensemble, avec une plus grande pr\u00e9cision pour les femmes de plus de 50 ans.<\/p>\n

“Notre test sanguin offre aux femmes un nouvel outil pour prendre en charge la sant\u00e9 de leurs seins”, d\u00e9clare le Dr Rinker. “Notre mission est d’int\u00e9grer la d\u00e9tection pr\u00e9coce dans les soins de sant\u00e9 de routine et notre partenariat avec Calian nous permet de faire un grand pas en avant au Canada pour influencer la fa\u00e7on dont le cancer est d\u00e9tect\u00e9 ici et dans le monde entier”.<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

Calian s’est associ\u00e9 \u00e0 Syantra pour proposer un nouvel outil de d\u00e9pistage du cancer du sein aux femmes dans plus de 100 villes du Canada.<\/p>\n","protected":false},"featured_media":385,"template":"","business_unit":[184,124],"solution":[],"industry":[144],"type_classification":[],"class_list":["post-1272","blog","type-blog","status-publish","has-post-thumbnail","hentry","business_unit-gse","business_unit-sante","industry-sante"],"acf":{"enable_related_resources_carousel":true,"related_resources_carousel_title":"Related Resources","related_resources_max_posts":3,"related_resources_max_per_type":0,"related_resources_override_solutions":[],"related_resources_override_industries":[],"related_resources_hide_excerpts":false},"yoast_head":"\nCalian CARES : Syantra et Calian collaborent pour permettre l'acc\u00e8s \u00e0 un test sanguin innovant de d\u00e9pistage du cancer du sein - Ressources<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.calian.com\/resources\/fr\/blogues\/calian-cares-syantra-and-calian-collaborate-to-provide-access-to-innovative-breast-cancer-screening-blood-test\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Calian CARES : Syantra et Calian collaborent pour permettre l'acc\u00e8s \u00e0 un test sanguin innovant de d\u00e9pistage du cancer du sein - Ressources\" \/>\n<meta property=\"og:description\" content=\"Calian s'est associ\u00e9 \u00e0 Syantra pour proposer un nouvel outil de d\u00e9pistage du cancer du sein aux femmes dans plus de 100 villes du Canada.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.calian.com\/resources\/fr\/blogues\/calian-cares-syantra-and-calian-collaborate-to-provide-access-to-innovative-breast-cancer-screening-blood-test\/\" \/>\n<meta property=\"og:site_name\" content=\"Ressources\" \/>\n<meta property=\"article:modified_time\" content=\"2025-01-27T19:00:47+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/sites.calian.com\/app\/uploads\/sites\/11\/2024\/03\/shutterstock_1062076370.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"768\" \/>\n\t<meta property=\"og:image:height\" content=\"420\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.calian.com\/resources\/fr\/blogues\/calian-cares-syantra-and-calian-collaborate-to-provide-access-to-innovative-breast-cancer-screening-blood-test\/\",\"url\":\"https:\/\/www.calian.com\/resources\/fr\/blogues\/calian-cares-syantra-and-calian-collaborate-to-provide-access-to-innovative-breast-cancer-screening-blood-test\/\",\"name\":\"Calian CARES : Syantra et Calian collaborent pour permettre l'acc\u00e8s \u00e0 un test sanguin innovant de d\u00e9pistage du cancer du sein - Ressources\",\"isPartOf\":{\"@id\":\"https:\/\/www.calian.com\/resources\/fr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.calian.com\/resources\/fr\/blogues\/calian-cares-syantra-and-calian-collaborate-to-provide-access-to-innovative-breast-cancer-screening-blood-test\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.calian.com\/resources\/fr\/blogues\/calian-cares-syantra-and-calian-collaborate-to-provide-access-to-innovative-breast-cancer-screening-blood-test\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/sites.calian.com\/app\/uploads\/sites\/11\/2024\/03\/shutterstock_1062076370.jpg\",\"datePublished\":\"2022-10-13T17:10:06+00:00\",\"dateModified\":\"2025-01-27T19:00:47+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.calian.com\/resources\/fr\/blogues\/calian-cares-syantra-and-calian-collaborate-to-provide-access-to-innovative-breast-cancer-screening-blood-test\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.calian.com\/resources\/fr\/blogues\/calian-cares-syantra-and-calian-collaborate-to-provide-access-to-innovative-breast-cancer-screening-blood-test\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/www.calian.com\/resources\/fr\/blogues\/calian-cares-syantra-and-calian-collaborate-to-provide-access-to-innovative-breast-cancer-screening-blood-test\/#primaryimage\",\"url\":\"https:\/\/sites.calian.com\/app\/uploads\/sites\/11\/2024\/03\/shutterstock_1062076370.jpg\",\"contentUrl\":\"https:\/\/sites.calian.com\/app\/uploads\/sites\/11\/2024\/03\/shutterstock_1062076370.jpg\",\"width\":768,\"height\":420},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.calian.com\/resources\/fr\/blogues\/calian-cares-syantra-and-calian-collaborate-to-provide-access-to-innovative-breast-cancer-screening-blood-test\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\/\/www.calian.com\/resources\/fr\/blogues\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Calian CARES : Syantra et Calian collaborent pour permettre l’acc\u00e8s \u00e0 un test sanguin innovant de d\u00e9pistage du cancer du sein\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.calian.com\/resources\/fr\/#website\",\"url\":\"https:\/\/www.calian.com\/resources\/fr\/\",\"name\":\"Ressources\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.calian.com\/resources\/fr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Calian CARES : Syantra et Calian collaborent pour permettre l'acc\u00e8s \u00e0 un test sanguin innovant de d\u00e9pistage du cancer du sein - Ressources","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.calian.com\/resources\/fr\/blogues\/calian-cares-syantra-and-calian-collaborate-to-provide-access-to-innovative-breast-cancer-screening-blood-test\/","og_locale":"fr_FR","og_type":"article","og_title":"Calian CARES : Syantra et Calian collaborent pour permettre l'acc\u00e8s \u00e0 un test sanguin innovant de d\u00e9pistage du cancer du sein - Ressources","og_description":"Calian s'est associ\u00e9 \u00e0 Syantra pour proposer un nouvel outil de d\u00e9pistage du cancer du sein aux femmes dans plus de 100 villes du Canada.","og_url":"https:\/\/www.calian.com\/resources\/fr\/blogues\/calian-cares-syantra-and-calian-collaborate-to-provide-access-to-innovative-breast-cancer-screening-blood-test\/","og_site_name":"Ressources","article_modified_time":"2025-01-27T19:00:47+00:00","og_image":[{"width":768,"height":420,"url":"https:\/\/sites.calian.com\/app\/uploads\/sites\/11\/2024\/03\/shutterstock_1062076370.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.calian.com\/resources\/fr\/blogues\/calian-cares-syantra-and-calian-collaborate-to-provide-access-to-innovative-breast-cancer-screening-blood-test\/","url":"https:\/\/www.calian.com\/resources\/fr\/blogues\/calian-cares-syantra-and-calian-collaborate-to-provide-access-to-innovative-breast-cancer-screening-blood-test\/","name":"Calian CARES : Syantra et Calian collaborent pour permettre l'acc\u00e8s \u00e0 un test sanguin innovant de d\u00e9pistage du cancer du sein - Ressources","isPartOf":{"@id":"https:\/\/www.calian.com\/resources\/fr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.calian.com\/resources\/fr\/blogues\/calian-cares-syantra-and-calian-collaborate-to-provide-access-to-innovative-breast-cancer-screening-blood-test\/#primaryimage"},"image":{"@id":"https:\/\/www.calian.com\/resources\/fr\/blogues\/calian-cares-syantra-and-calian-collaborate-to-provide-access-to-innovative-breast-cancer-screening-blood-test\/#primaryimage"},"thumbnailUrl":"https:\/\/sites.calian.com\/app\/uploads\/sites\/11\/2024\/03\/shutterstock_1062076370.jpg","datePublished":"2022-10-13T17:10:06+00:00","dateModified":"2025-01-27T19:00:47+00:00","breadcrumb":{"@id":"https:\/\/www.calian.com\/resources\/fr\/blogues\/calian-cares-syantra-and-calian-collaborate-to-provide-access-to-innovative-breast-cancer-screening-blood-test\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.calian.com\/resources\/fr\/blogues\/calian-cares-syantra-and-calian-collaborate-to-provide-access-to-innovative-breast-cancer-screening-blood-test\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.calian.com\/resources\/fr\/blogues\/calian-cares-syantra-and-calian-collaborate-to-provide-access-to-innovative-breast-cancer-screening-blood-test\/#primaryimage","url":"https:\/\/sites.calian.com\/app\/uploads\/sites\/11\/2024\/03\/shutterstock_1062076370.jpg","contentUrl":"https:\/\/sites.calian.com\/app\/uploads\/sites\/11\/2024\/03\/shutterstock_1062076370.jpg","width":768,"height":420},{"@type":"BreadcrumbList","@id":"https:\/\/www.calian.com\/resources\/fr\/blogues\/calian-cares-syantra-and-calian-collaborate-to-provide-access-to-innovative-breast-cancer-screening-blood-test\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/www.calian.com\/resources\/fr\/blogues\/"},{"@type":"ListItem","position":2,"name":"Calian CARES : Syantra et Calian collaborent pour permettre l’acc\u00e8s \u00e0 un test sanguin innovant de d\u00e9pistage du cancer du sein"}]},{"@type":"WebSite","@id":"https:\/\/www.calian.com\/resources\/fr\/#website","url":"https:\/\/www.calian.com\/resources\/fr\/","name":"Ressources","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.calian.com\/resources\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"}]}},"_links":{"self":[{"href":"https:\/\/resources.calian.com\/fr\/wp-json\/wp\/v2\/blog\/1272","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/resources.calian.com\/fr\/wp-json\/wp\/v2\/blog"}],"about":[{"href":"https:\/\/resources.calian.com\/fr\/wp-json\/wp\/v2\/types\/blog"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/resources.calian.com\/fr\/wp-json\/wp\/v2\/media\/385"}],"wp:attachment":[{"href":"https:\/\/resources.calian.com\/fr\/wp-json\/wp\/v2\/media?parent=1272"}],"wp:term":[{"taxonomy":"business_unit","embeddable":true,"href":"https:\/\/resources.calian.com\/fr\/wp-json\/wp\/v2\/business_unit?post=1272"},{"taxonomy":"solution","embeddable":true,"href":"https:\/\/resources.calian.com\/fr\/wp-json\/wp\/v2\/solution?post=1272"},{"taxonomy":"industry","embeddable":true,"href":"https:\/\/resources.calian.com\/fr\/wp-json\/wp\/v2\/industry?post=1272"},{"taxonomy":"type_classification","embeddable":true,"href":"https:\/\/resources.calian.com\/fr\/wp-json\/wp\/v2\/type_classification?post=1272"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}